Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: A meta analysis
- 30 April 2006
- journal article
- research article
- Published by Elsevier BV in Schizophrenia Research
- Vol. 83 (2-3), 185-192
- https://doi.org/10.1016/j.schres.2006.01.010
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: III. Lack of association of CYP3A4 and CYP2D6 gene polymorphismsSchizophrenia Research, 2005
- Neuroleptic-induced Movement Disorders: An OverviewPsychiatric Clinics of North America, 2005
- No association between 12 dopaminergic genes and schizophrenia in a large Dutch sampleAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2005
- Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphismThe Pharmacogenomics Journal, 2004
- Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patientsJournal of Neural Transmission, 2001
- Tardive Drug-Induced Extrapyramidal SyndromesPharmacopsychiatry, 2000
- Changes in negative symptoms and the risk of tardive dyskinesia: a longitudinal studyActa Psychiatrica Scandinavica, 2000
- Tardive dyskinesia and DRD2, DRD3, DRD4, 5-HT2A variants in schizophrenia: an association study with repeated assessmentInternational Journal of Neuropsychopharmacology, 1999
- Diabetes mellitus and tardive dyskinesiaPublished by Cambridge University Press (CUP) ,1996
- Proposed Schizophrenia-Related Gene Polymorphism: Expression of the Ser9Gly Mutant Human Dopamine D3Receptor with the Semliki Forest Virus SystemBiochemical and Biophysical Research Communications, 1996